Extra-corporeal vascular conduit

• US 6,761,700 B2
• Filed: 02/09/2001
• Issued: 07/13/2004
• Est. Priority Date: 02/09/2001
• Status: Expired due to Term

• Current Assignee: TC1 LLC (Abbott Laboratories Incorporated)
• Original Assignee: ORQIS Medical Corporation
• Inventors: Sirimanne, Laksen, Viole, Anthony
• Primary Examiner(s): Bennett, Henry
• Assistant Examiner(s): PATEL, NIHIR B
• Application Number:
  US09/780,083
• Publication Number:
  US 20020111577A1
• Time in Patent Office: 1,250 Days
• Field of Search: 604/4.01, 604/5.01, 604/6.16, 604/7, 604/8, 604/48, 604/500, 604/104, 604/105, 604/106, 604/174, 604/264, 604/523, 604/524, 210/645, 210/646, 422/44-48, 623/1, 623/11, 623/12, 623/1.1, 623/1.13, 623/1.14, 623/1.24
• US Class Current: 604/4.01
• CPC Class Codes: A61M 1/3655 Arterio-venous shunts or fistulae
• CPC Class Codes: A61M 39/105 Multi-channel connectors or couplings, e.g. for connecting multi-lumen tubes multi-channel connectors in general F16L37/56

Abstract

An extracorporeal vascular conduit for circulating blood outside a patient'"'"'s body over an extended period of time in a manner that minimizes risk of thrombosis and complement activation and maximizes the ability of a patient to be ambulatory during recovery stages. The inventive vascular conduit comprises a first biocompatible material and a second synthetic material that is employed over a portion of the biocompatible material that extends outside the patient'"'"'s body when is use. The majority of the portion that extends within the patient'"'"'s body remains uncoated. A third synthetic material is applied around the conduit near the distal end of the second coating material of the catheter to permit a physician to secure the catheter to the patient'"'"'s skin to minimize relative movement.

Claims

1. An extracorporeal vascular conduit comprising at least in part a first synthetic biocompatible material, said vascular conduit having a first portion with a first distal end configured to be attached to at least one blood vessel of a patient, said first portion comprising said biocompatible material and configured to compatibly reside within the patient'"'"'s body for an extended period of time without adverse effects to said patient, said vascular conduit having a second portion also comprising said biocompatible material and being configured so as to reside outside the patient'"'"'s body for extended periods of time without significantly adversely affecting the patient, said second portion having a proximal end configured to connect to an external component employed in the treatment of said patient, the vascular conduit further comprising a second synthetic material that covers a substantial portion of said second portion of said vascular conduit, said synthetic material providing a substantially impervious and nonporous barrier between the ambient environment and any fluid flowing:

within the interior of the vascular conduit when said vascular conduit is in use.

2. The vascular conduit of claim 1 wherein the first biocompatible material is PTFE.

3. The vascular conduit of claim 1 wherein the second synthetic material is a polymer.

4. The vascular conduit of claim 1 further comprising a sleeve comprising a third synthetic biocompatible material having a generally textile characteristic, said sleeve positioned on said conduit so that when said conduit is applied to a patient, the sleeve is positioned at and surrounding the interface of the first and second portions of said vascular conduit, said sleeve serving to provide a substrate upon which a treating physician may secure said vascular conduit to the patient to minimize relative movement therebetween.

5. The vascular conduit of claim 1 further comprising an anchoring device.

6. The vascular conduit of claim 4 wherein the third material is polyester.

11. The extracorporeal vascular conduit of claim 1 wherein the distal end further comprises at least one additional connection conduit configured to be attached to a blood vessel.

7. An extracorporeal vascular conduit comprising a first portion comprising a first synthetic biocompatible material, a second portion comprising said biocompatible material and a second synthetic non-porous coating material, and a third portion enveloping some of the first and second portions and comprising a third synthetic material, said first portion having a distal end configured to be secured to a blood vessel of a patient and having a proximal end configured to be connected to an external component used during treatment of the patient.

8. A method of circulating fluid outside a patient'"'"'s body comprising the steps of:

providing an extracorporeal vascular conduit comprising a first and second portion, said first and second portion comprising a first synthetic biocompatible material, said second portion further comprising a second synthetic coating material;

attaching a distal end of the vascular conduit to a first blood vessel location; and

connecting a proximal end of the vascular conduit to an extracorporeal device used in the treatment of the patient.

9. The method of claim 8 wherein said first synthetic biocompatible material is ePTFE.

10. The method of claim 8 wherein said second synthetic material is silicone.

12. An extracorporeal conduit system comprising a vascular shunt and a vascular conduit said vascular shunt comprising a first synthetic biocompatible material, said vascular shunt having a first end and a second end configured to be attached to a blood vessel of a patient, said vascular conduit comprising said biocompatible material, said vascular conduit having a first portion with a first distal end configured to be attached to said vascular shunt, said shunt and said first portion configured to compatibly reside within the patient'"'"'s body for an extended period of time without adverse effects to said patient, said vascular conduit having a second portion also comprising the first biocompatible material, said second portion being configured so as to reside outside the body for extended periods of time without significantly adversely affecting the patient.

13. The vascular shunt of claim 12 further comprising an access port.

14. The vascular shunt of claim 12 wherein said biocompatible material is ePTFE.